fda compounded semaglutide enforcement news Warns About Versions of Ozempic and Wegovy FDA cracks down on 'misleading'

Semaglutide is administered once weekly, ideally on the same day each week to maintain consistent medication levels

GHK-Cu half-life and blood clearance Plasma half-life: Approximately 30-60 minutes in circulation Varies by administration route Injectable: ~30-45 minutes Topical: Similar once absorbed (slower absorption though) Very short compared to some peptides What half-life means: Time for 50% of peptide to clear from blood After one half-life: 50% remains After two half-lives (1-2 hours): 25% remains After three half-lives (1.5-3 hours): 12.5% remains After four half-lives (2-4 hours): 6.25% remains Essentially cleared within 4-6 hours GHK-Cu clearance timeline: Why such short half-life: Small peptide (easily filtered by kidneys) Rapidly metabolized by enzymes Not designed for long circulation Acts quickly at cellular level then clears Learn peptide basics at SeekPeptides - explore what are peptides , how peptides work , and copper peptides GHK-Cu guide

The SELS rs34713741 polymorphism is associated with susceptibility to colorectal cancer and gastric cancer: a meta-analysis

It depends on your specific diagnosis, medications, and overall health history

Contraindications include medullary thyroid cancer and multiple endocrine neoplasia 2 (the same for Wegovy and Ozempic)